These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23756646)

  • 1. Obstacles to the recognition of medical prescriptions issued in one EU country and presented in another.
    San Miguel L; Baeten R; Remmen R; Busse R; Gil J; Knai C; Mäkinen M; Rubert G; McKee M
    Eur J Public Health; 2013 Dec; 23(6):972-4. PubMed ID: 23756646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What to do when presented with a prescription from another European country: insight from a qualitative study of pharmacists in England.
    Knai C; Saliba V; Davies J; McKee M; Khoshaba B; Lago E; San Miguel L
    Int J Pharm Pract; 2014 Apr; 22(2):112-8. PubMed ID: 23849254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database.
    Liou WS; Hsieh SC; Chang WY; Wu GH; Huang HS; Lee C
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):752-9. PubMed ID: 23625864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden.
    Andersson K; Sonesson C; Petzold M; Carlsten A; Lönnroth K
    Pharmacoepidemiol Drug Saf; 2005 May; 14(5):341-8. PubMed ID: 15624198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiencies in medical prescriptions in a Sudanese hospital.
    Yousif E; Ahmed AM; Abdalla ME; Abdelgadir MA
    East Mediterr Health J; 2006 Nov; 12(6):915-8. PubMed ID: 17333840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
    Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
    Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational prescribing in primary care. A role for clinical pharmacology in Europe?
    Walley T
    Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():31-5. PubMed ID: 9800727
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of computerised prescribing on use of antibiotics.
    Newby DA; Fryer JL; Henry DA
    Med J Aust; 2003 Mar; 178(5):210-3. PubMed ID: 12603183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of multiple prescriptions dispensed in Saudi Arabia.
    Ahmed KZ; Al-Saadi AR
    Pak J Pharm Sci; 2005 Apr; 18(2):1-2. PubMed ID: 16431388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases.
    Ng-Mak DS; Chen YT; Ho TW; Stanford B; Roset M
    Cephalalgia; 2012 Sep; 32(12):875-87. PubMed ID: 22833612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia.
    Hazra M; Uchida H; Sproule B; Remington G; Suzuki T; Mamo DC
    Psychiatry Clin Neurosci; 2011 Dec; 65(7):676-8. PubMed ID: 22176287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Think INN, prescribe INN, dispense INN: good professional practice.
    Prescrire Int; 2000 Dec; 9(50):184-90. PubMed ID: 11475502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of pharmaceutical prescriptions across the European Union: a comparison of five Member States' policies and practices.
    Miguel LS; Augustin U; Busse R; Knai C; Rubert G; Sihvo S; Baeten R
    Health Policy; 2014 Jun; 116(2-3):206-13. PubMed ID: 24290875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abusive prescribing of controlled substances--a pharmacy view.
    Betses M; Brennan T
    N Engl J Med; 2013 Sep; 369(11):989-91. PubMed ID: 23964897
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicators.
    Al-Niemat SI; Bloukh DT; Al-Harasis MD; Al-Fanek AF; Salah RK
    Saudi Med J; 2008 May; 29(5):743-8. PubMed ID: 18454225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey.
    Sturm HB; van Gilst WH; Veeger N; Haaijer-Ruskamp FM
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):96-103. PubMed ID: 16528759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.